Candel Therapeutics SG&A Expense (TTM) Trends

Candel Therapeutics Inc (CADL)

6.65 -0.06 (-0.89%) USD | NASDAQ | Oct 04, 16:00

6.53 -0.12 (-1.80%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	13.47M
March 31, 2024	13.52M
December 31, 2023	13.88M
September 30, 2023	13.98M
June 30, 2023	14.50M
March 31, 2023	14.62M
December 31, 2022	14.06M
September 30, 2022	14.82M

Date	Value
June 30, 2022	14.07M
March 31, 2022	12.35M
December 31, 2021	10.69M
September 30, 2021	9.392M
June 30, 2021	7.564M
March 31, 2021	6.379M
December 31, 2020	5.172M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.172M

Minimum

Dec 2020

14.82M

Maximum

Sep 2022

11.90M

Average

13.52M

Median

Mar 2024

SG&A Expense (TTM) Benchmarks